NCFO Global Overview
As of 31 Dec 2025 Financial Review Required
NCFO Health Score
Net Operating Cash Flow YTD vs LY
$360M
▼ 2.5%
Conversion Ratio:
89%
⚠️
Moderate Risk
Expansion changes impacting APAC
Cash Conversion Cycle (DCC)
DSO 58↑ +2
DIO 60↑ +1
DPO 42↑ +3
Net DCC: 76
(+5 vs Target)
Cash Forecast Confidence
Forecast Accuracy
92%
+9.2%
Best
Base
Worst
Next 90-day cash path
Working Capital Quality
AR
14%
Overdue AR > 60 days
AP
8%
Early Payment Leakage
INV
21%
Excess Stock Ratio
Cash Trapped Quality
Overdue AR < 60 days
Slow-Moving % Inventory
D-Zero Execution Impact
$150M
Cash realized YTD
$25M at risk
across near-term initiatives
Pipeline: $80M
Next Milestones
May 1: APAC Working Capital
May 5: LATAM Inventory Discounts
Top Cash Signals
Immediate Risks
EMEA AR ageing >60 days exposing $35M cash risk
North America DPO down 6 days, impacting short-term liquidity
Upside Opportunity
Q2 performance milestone could unlock $18M bonus cash